Table 1.
Comparison of Baseline, Clinical, Laboratory, and Echocardiographic Characteristics Between Groups
| Variables | Dipper HTN Group (n=198) | Nondipper HTN Group (n=119) | P Value |
|---|---|---|---|
| Age, y | 51.7±5.1 | 53.4±7.6 | .019 |
| Male sexa | 94 (47.5%) | 48 (40.3%) | .131 |
| BMI, kg/m2 | 29.1±3.7 | 28.5±3.5 | .189 |
| BSA, m2 | 1.83±0.16 | 1.80±0.15 | .090 |
| Heart rate, beats per min | 76.6±11.8 | 77.5±11.9 | .562 |
| Current smokinga | 74 (37.4%) | 35 (29.4%) | .092 |
| Laboratory findings | |||
| Fasting glucose, mg/dL | 89.6±8.1 | 88.4±9.8 | .531 |
| Total cholesterol, mg/dL | 192.4±29.4 | 189.5±33.4 | .412 |
| Triglycerides, mg/dL | 176.7±47.1 | 166.4±42.3 | .049 |
| HDL cholesterol, mg/dL | 40.1±6.2 | 41.4±6.2 | .090 |
| LDL cholesterol, mg/dL | 115.4±24.9 | 113.8±27.3 | .584 |
| Creatinin, mg/dL | 0.77.0±0.12 | 0.79.8±0.14 | .077 |
| hs‐CRP, mg/dL | 0.70±0.26 | 0.86±0.34 | <.001 |
| NT‐proBNP, pg/mL | 89.9±33.1 | 127.2±53.0 | <.001 |
| hs‐cTnT, ng/L | 5.7±3.0 | 9.0±2.7 | <.001 |
| Hemoglobin, g/dL | 13.9±2.7 | 13.8±3.1 | .672 |
| Echocardiography | |||
| Left atrial diameter, mm | 34.1±3.5 | 33.8±3.9 | .512 |
| LVID, mm | 45.4±4.3 | 46.0±3.8 | .262 |
| IVSt, mm | 10.9±1.7 | 11.5±2.7 | .015 |
| PWt, mm | 10.2±1.5 | 10.4±1.9 | .297 |
| Ejection fraction, % | 67±4.9 | 65.4±4.0 | .002 |
| RWt, mm | 0.45±0.1 | 0.46±0.1 | .665 |
| LVMI, g/m2 | 109.9±27.2 | 119.7±31.6 | .004 |
Abbreviations: BMI, body mass index; BSA, body surface area; HDL, high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; hs‐cTnT, high‐sensitivity cardiac troponin T; HTN, hypertension; IVSt, interventricular septal thickness; LDL, low‐density lipoprotein; LVID, left ventricular internal diameter; LVMI, left ventricular mass index; NT‐proBNP, N‐terminal pro‐brain natriuretic peptide; PWt, posterior wall thickness, RWt, relative wall thickness. aChi‐square. Bold values indicate significance. Values are expressed as mean±standard deviation or number (percentage).